Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.6K
Overview
47.6K
Active versus Passive Immunity01:31

Active versus Passive Immunity

7.8K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

586
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
586
Standard Precaution01:26

Standard Precaution

2.4K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.4K
Hand hygiene01:23

Hand hygiene

4.9K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
4.9K
PPE Use in Healthcare Settings I: Donning01:22

PPE Use in Healthcare Settings I: Donning

1.4K
Donning PPE must be completed before contact with the patient. This process protects from infectious agents. The sequence and action included in each donning are critical, and the steps must be systematic to avoid exposure to pathogens. The institutional policy also needs to be followed while donning PPE. The pre-donning preparations are gathering equipment, inspecting the PPE equipment for tears, holes, or damage, removing jewelry, removing any garments below the elbows, and tying the hair...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DLBCL-microenvironment interactions: cytokine profiling and ECM-mediated ibrutinib resistance in a 3D bone-based model.

Medical oncology (Northwood, London, England)·2026
Same author

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same author

Differential effects of legacy and new-generation perfluoro-alkyl substances on in vitro differentiation and immunoglobulins production by B cells.

Environment international·2026
Same author

Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort.

British journal of haematology·2026
Same author

Sarcoid-like reactions: a comprehensive review of granulomatous diseases mimicking sarcoidosis.

Expert review of clinical immunology·2026

Related Experiment Video

Updated: Oct 30, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Vaccination in PADs.

Cinzia Milito1, Valentina Soccodato1, Giulia Collalti1

  • 1Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Vaccines
|July 2, 2021
PubMed
Summary

Primary antibody deficiencies (PADs), the most common primary immunodeficiencies, impact humoral immunity. Vaccination strategies vary, with inactivated vaccines recommended and live attenuated vaccines cautioned against in PAD patients.

Keywords:
antibody deficiencyimmunizationimmunodeficiencyvaccination recommendations

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.6K

Related Experiment Videos

Last Updated: Oct 30, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.6K

Area of Science:

  • Immunology
  • Vaccinology
  • Clinical Medicine

Background:

  • Primary antibody deficiencies (PADs) are the most common primary immunodeficiencies (PIDs).
  • PADs encompass various conditions including agammaglobulinemia, CVID, and specific antibody deficiencies.
  • Vaccination plays a crucial role in managing PADs, offering therapeutic, diagnostic, and prognostic benefits.

Purpose of the Study:

  • To review the role and safety of different vaccine types in patients with primary antibody deficiencies.
  • To discuss current recommendations for vaccination in PAD patients, including COVID-19 vaccines.
  • To highlight the importance of tailored vaccination strategies based on immunodeficiency type and vaccine characteristics.

Main Methods:

  • Literature review of vaccination strategies in primary immunodeficiencies.
  • Analysis of vaccine classifications (live attenuated, inactivated, mRNA, vector).
  • Examination of European Medicines Agency (EMA) and European Society for Immunodeficiencies (ESID) recommendations.

Main Results:

  • Inactivated vaccines can be administered to PAD patients, though protective responses may be limited.
  • Live attenuated vaccines are generally not recommended for individuals with major antibody deficiencies.
  • COVID-19 vaccinations are recommended for PAD patients per ESID guidelines, despite limited specific safety and efficacy data.

Conclusions:

  • Vaccination is a key component of PAD management, requiring careful selection of vaccine types.
  • Inactivated and mRNA vaccines are generally considered safer options for PAD patients.
  • Further research is needed to establish definitive safety and efficacy data for various vaccines in PAD populations.